2,253 research outputs found
Are coffee silverskin extracts safe for topical use? An in vitro and in vivo approach
Recent changes in regulatory requirements and social views on animal testing have incremented the development of reliable alternative tests for predicting skin and ocular irritation potential of products based on new raw materials. In this regard, botanical ingredients used in cosmetic products are among those materials, and should be carefully reviewed concerning the potential presence of irritant constituents. In particular, cosmetic products used on the face, in vicinity of the eyes or that may come in contact with mucous membranes, should avoid botanical ingredients that contain, or are suspected to contain, such ingredients. In this study, we aimed to evaluate the effect of a new cosmetic ingredient, namely, coffee silverskin (CS), with an in vitro skin and ocular irritation assay using reconstructed human epidermis, EpiSkin™, and human corneal epithelial model, SkinEthics™ HCE, and an in vivo assay. Three different extracts of CS were evaluated. The histology of the models after extracts applications was analysed. The in vitro results demonstrated that extracts were not classified as irritant and the histological analyses proved that extracts did not affect both models structure. The content of caffeine, 5-hydroxymethyl furfural and chlorogenic acid was quantified after the epidermal assay. The in vivo test carried out with the most promising extract (hydroalcoholic) showed that, with respect to irritant effects, these extracts can be regarded as safe for topical application
Delignification of Cistus ladanifer biomass by organosolv and alkali processes
Residues of Cistus ladanifer obtained after commercial steam distillation for essential oil
production were evaluated to produce cellulose enriched solids and added-value lignin-derived
compounds. The delignification of extracted (CLRext) and extracted and hydrothermally pretreated
biomass (CLRtreat) was studied using two organosolv processes, ethanol/water mixtures (EO), and
alkali-catalyzed glycerol (AGO), and by an alkali (sodium hydroxide) process (ASP) under different
reaction conditions. The phenolic composition of soluble lignin was determined by capillary zone
electrophoresis and by Py-GC/MS, which was also used to establish the monomeric composition of
both the delignified solids and isolated lignin. The enzymatic saccharification of the delignified solids
was also evaluated. The ASP (4% NaOH, 2 h) lead to both the highest delignification and enzymatic
saccharification (87% and 79%, respectively). A delignification of 76% and enzymatic hydrolysis
yields of 72% were obtained for AGO (4% NaOH) while EO processes led to lower delignification
(maximum lignin removal 29%). The residual lignin in the delignified solids were enriched in Gand
H-units, with S-units being preferentially removed. The main phenolics present in the ASP and
AGO liquors were vanillic acid and epicatechin, while gallic acid was the main phenolic in the EO
liquors. The results showed that C. ladanifer residues can be a biomass source for the production of
lignin-derivatives and glucan-rich solids to be further used in bioconversion processesinfo:eu-repo/semantics/publishedVersio
Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis
PURPOSE: We reproduced a non-bacterial experimental model to assess bladder inflammation and urinary glycosaminoglycans (GAG) excretion and examined the effect of dimethyl sulfoxide (DMSO). MATERIALS AND METHODS: Female rats were instilled with either protamine sulfate (PS groups) or sterile saline (control groups). At different days after the procedure, 24 h urine and bladder samples were obtained. Urinary levels of hyaluronic acid (HA) and sulfated glycosaminoglycans (S-GAG) were determined. Also to evaluate the effect of DMSO animals were instilled with either 50% DMSO or saline 6 hours after PS instillation. To evaluate the effect of DMSO in healthy bladders, rats were instilled with 50% DMSO and controls with saline. RESULTS: In the PS groups, bladder inflammation was observed, with polymorphonuclear cells during the first days and lymphomononuclear in the last days. HA and S-GAG had 2 peaks of urinary excretion, at the 1st and 7th day after PS injection. DMSO significantly reduced bladder inflammation. In contrast, in healthy bladders, DMSO produced mild inflammation and an increase in urinary HA levels after 1 and 7 days and an increase of S-GAG level in 7 days. Animals instilled with PS and treated with DMSO had significantly reduced levels of urinary HA only at the 1st day. Urinary S-GAG/Cr levels were similar in all groups. CONCLUSIONS: Increased urinary levels of GAG were associated with bladder inflammation in a PS-induced cystitis model. DMSO significantly reduced the inflammatory process after urothelial injury. Conversely, this drug provoked mild inflammation in normal mucosa. DMSO treatment was shown to influence urinary HA excretion
TRADUÇÃO E ADAPTAÇÃO CULTURAL DO “DIABETES EATING PROBLEM SURVEY – REVISED” PARA O BRASIL
Objective: To translate and culturally adapt the Diabetes Eating Problem Survey – Revised for the Portuguese language of Brazil. Method: Methodological study, with translation, synthesis of translations, back translation, submission to the committee of experts, pre-test and opinion of the original author. It had two translators, two back translators, expert committee and pre-test with 30 people. Results: Through evaluation of a committee of judges and pre-test, evidence of content validity was obtained and adequate semantic analysis was performed. Content validity index higher than 0.90 was obtained. The pre-test showed valid instrument items, easy to understand and answer for the target population. Conclusion: Semantic, idiomatic, conceptual and cultural equivalences of the adapted instrument were achieved, which showed evidence of validity of its content.Objetivo: Traducir y adaptar culturalmente la Encuesta de Problemas de Alimentación de la Diabetes – Revisada para el idioma portugués de Brasil. Método: Estudio metodológico, con traducción, síntesis de traducciones, retrotraducción, presentación al comité de expertos, pre-test y opinión del autor original. Contó con dos traductores, dos traductores traseros, comité de expertos y pre-test con 30 personas. Resultados: A través de la evaluación de un comité de jueces y pre-test, se obtuvieron evidencias de validez de contenido y se realizó un análisis semántico adecuado. Se obtuvo un índice de validez de contenido superior a 0,90. La prueba previa mostró elementos de instrumentos válidos, fáciles de entender y responder para la población objetivo. Conclusión: Se lograron equivalencias semánticas, idiomáticas, conceptuales y culturales del instrumento adaptado, que mostraron evidencia de validez de su contenido.Objetivo: Traduzir e adaptar culturalmente o Diabetes Eating Problem Survey – Revised para a língua portuguesa do Brasil. Método: Estudo metodológico, com tradução, síntese das traduções, retrotradução, submissão a comitê de especialistas, pré-teste e parecer do autor original. Teve dois tradutores, dois retrotradutores, comitê de especialistas e pré-teste com 30 pessoas. Resultados: Mediante avaliação de comitê de juízes e realização do pré-teste, foi alcançada evidência de validade de conteúdo e realizada análise semântica adequada. Obteve-se índice de validade de conteúdo superior a 0,90. O pré-teste mostrou itens do instrumento válidos, fáceis de compreender e responder pela população-alvo. Conclusão: Alcançaram-se equivalências semântica, idiomática, conceitual e cultural do instrumento adaptado, que mostrou evidência de validade de seu conteúdo.
Implantação de registro informatizado em anestesia em hospital de ensino : análise preliminar de resultados das primeiras 4718 fichas anestésicas digitais (FAD)
Brazilian network for HIV Drug Resistance Surveillance (HIV-BresNet): a survey of treatment-naive individuals
Introduction: In Brazil, more than 487,450 individuals are currently undergoing antiretroviral treatment. In order to monitor the transmission of drug-resistant strains and HIV subtype distribution in the country, this work aimed to estimate its prevalence and to characterize the nationwide pretreatment drug resistance in individuals recently diagnosed with HIV between 2013 and 2015. Methods: The HIV threshold survey methodology (HIV-THS, WHO) targeting antiretroviral-naive individuals with recent HIV diagnosis was utilized, and subjects were selected from 51 highly populated cities in all five Brazilian macroregions. The HIV pol genotypic test was performed by genomic sequencing. Results: We analysed samples from 1568 antiretroviral-naive individuals recently diagnosed with HIV, and the overall transmitted drug resistance (TDR) prevalence was 9.5% (150 sequences). The regional prevalence of resistance according to Brazilian geographical regions was 9.4% in the northeast, 11.2% in the southeast, 6.8% in the central region, 10.2% in the north and 8.8% in the south. The inhibitor-specific TDR prevalence was 3.6% for nucleoside reverse transcriptase inhibitors (NRTIs), 5.8% for non-nucleoside reverse transcriptase inhibitors (NNRTIs) and 1.6% for protease inhibitors (PIs)1.0% of individuals presented resistance to more than one class of inhibitors. Overall, subtype B was more prevalent in every region except for the southern, where subtype C prevails. Conclusions: To the best of our knowledge, this is the first TDR study conducted in Brazil with nationwide representative sampling. The TDR prevalence revealed a moderate rate in the five Brazilian geographical regions, although some cities presented higher TDR prevalence rates, reaching 14% in Sao Paulo, for example. These results further illustrate the importance of surveillance studies for designing future strategies in primary antiretroviral therapy, aiming to mitigate TDR, as well as for predicting future trends in other regions of the globe where mass antiretroviral (ARV) treatment was implemented.Brazilian Ministry of HealthUniv Fed Rio de Janeiro, Lab Virol Mol, Dept Genet IB, Rio De Janeiro, RJ, BrazilFdn Med Trop Amazonas, Manaus, Amazonas, BrazilLAPI Univ Fed Bahia, Hosp Univ Prof Edgar Santos, Lab Pesquisa, Salvador, BA, BrazilLab Cent Saude Publ Ceara Lacen CE, Fortaleza, Ceara, BrazilLab Cent Saude Publ Dist Fed, Setor Grandes Areas Norte SGAN 601, Brasilia, DF, BrazilUniv Fed Minas Gerais UFMG, Fac Med, Lab Imunol & Biol Mol DIP, Belo Horizonte, MG, BrazilLab Cent Saude Publ Mato Grosso Sul, Campo Grande, MS, BrazilLab Cent Saude Publ Pernambuco, Recife, PE, BrazilLab Municipal Curitiba, Curitiba, PR, BrazilFiocruz MS, Lab AIDS & Imunol Mol, Dept Imunol, Rio De Janeiro, RJ, BrazilUniv Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Carga Viral, Rio de Janeiro, RJ, BrazilInst Biol Exercito, Rio De Janeiro, RJ, BrazilLab Cent Saude Publ Rio Grande Sul, Porto Alegre, RS, BrazilLab Hosp Nossa Senhora Conceicao, Porto Alegre, RS, BrazilLab Cent Saude Publ Santa Catarina, Florianopolis, SC, BrazilUNESP, Lab Biol Mol Hemocentro Botucatu, Fac Med, Botucatu, SP, BrazilUniv Estadual Campinas, Lab Pesquisa AIDS, Hosp Clin, Campinas, SP, BrazilInst Adolfo Lutz Sao Jose do Rio Preto, Lab Biol Mol, Sao Jose Do Rio Preto, SP, BrazilUniv Fed Sao Paulo UNIFESP, Escola Paulista Med, Lab Retrovirol, Sao Paulo, SP, BrazilInst Adolfo Lutz Cent, Lab Retrovirus, Ctr Virol, Nucleo Doencas Sanguineas & Sexuais, Sao Paulo, SP, BrazilMinist Saude, Dept Vigilancia Prevencao & Controle DST AIDS & H, Setor Adm Fed Sul SAFS 02, Secretaria Vigilancia Saude, Brasilia, DF, BrazilUniv Brasilia, Programa Pos Grad Saude Colet, Fac Med, Fac Ciencias Saude, Brasilia, DF, BrazilUniv Sao Paulo, Fac Med, Sao Paulo, SP, BrazilUniv Fed Sao Paulo UNIFESP, Escola Paulista Med, Lab Retrovirol, Sao Paulo, SP, BrazilBMH: TC 298/12Web of Scienc
INTESTINAL AND PULMONARY INFECTION BY Cryptosporidium parvum IN TWO PATIENTS WITH HIV/AIDS
Enxaqueca em 746 pacientes com esclerose múltipla
Enxaqueca piora o sofrimento do paciente que tem esclerose múltipla (EM). ID-migraine é uma ferramenta útil para seleção de pacientes com enxaqueca e Migraine Disability Assessment (MIDAS) é um questionário que avalia o impacto da doença. O objetivo do presente estudo foi avaliar a presença e impacto de enxaqueca em pacientes com EM. Métodos: Pacientes diagnosticados com EM e tratados em clínicas especializadas foram convidados a responder um questionário online se também apresentassem cefaleia. Resultados: O estudo incluiu 746 participantes com cefaleia e EM que preencheram completamente as respostas. Foram 625 mulheres e 121 homens, sendo 69% dos pacientes com idade entre 20 e 40 anos. Enxaqueca foi identificada em 404 pacientes (54,1%) e moderado a grave impacto da doença foi observado em 68,3% dos casos. Conclusão: Enxaqueca é uma cefaleia primária frequente e incapacitante relatada por pacientes com EM.Migraine adds to the burden of patients suffering from multiple sclerosis (MS). The ID-migraine is a useful tool for screening migraine, and the Migraine Disability Assessment questionnaire can evaluate disease burden. The aim of the present study was to assess the presence and burden of migraine in patients with MS. Methods: Patients diagnosed with MS attending specialized MS units were invited to answer an online survey if they also experienced headache. Results: The study included 746 complete responses from patients with MS and headache. There were 625 women and 121 men, and 69% of all the patients were aged between 20 and 40 years. Migraine was identified in 404 patients (54.1%) and a moderate-to-high burden of disease was observed in 68.3% of the patients. Conclusion: Migraine is a frequent and disabling type of primary headache reported by patients with MS
- …